Patent directory · USPTO A61K / A61P
Patents matching “Sangamo Therapeutics, Inc.”
106 pharma patents match "Sangamo Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 106 pharmaceutical patents matching "Sangamo Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11504389
Tau modulators and methods and compositions for delivery thereof
granted -
US 11492643
Methods and compositions for treatment of a genetic condition
granted -
US 11452782
Liver-specific constructs factor VIII expression cassettes and methods of use thereof
granted -
US 11439666
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
granted -
US 11421007
Zinc finger protein compositions for modulation of huntingtin (Htt)
granted -
US 11401512
Engineered target specific nucleases
granted -
US 11352631
Targeted disruption of the T cell receptor
granted -
US 11311574
Methods and compositions for targeted cleavage and recombination
granted -
US 11285175
Targeted disruption of the MHC cell receptor
granted -
US 11235026
Methods and compositions for modulating PD1
granted -
US 11236175
T cell modifying compounds and uses thereof
granted -
US 11219695
Methods and compositions for the treatment of Fabry disease
granted -
US 11149321
Methods and compositions for targeted single-stranded cleavage and targeted integration
granted -
US 11123443
Htt repressors and uses thereof
granted -
US 11110154
Methods and compositions for treating Huntington's Disease
granted -
US 11041174
Compositions for linking DNA-binding domains and cleavage domains
granted -
US 11040115
Method for the treatment of lysosomal storage diseases
granted -
US 11020492
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
granted -
US 11021696
Nuclease-mediated regulation of gene expression
granted -
US 10975393
Engineered target specific nucleases
granted -
US 10975375
Methods and compositions for regulation of transgene expression
granted -
US 10968261
Methods and compositions for genome engineering
granted -
US 10960085
Modulation of liver genes
granted -
US 10918668
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
granted